Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1136 of 1,261
  1. US 6869984

    Dental composition kit

    KURARAY CO., LTD. · Granted Mar 22, 2005 · Expires Mar 17, 2025

    expired
  2. US 6869924

    Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 22, 2005 · Expires Mar 17, 2025

    expired
  3. US 6869787

    Ricin vaccine and methods of making and using thereof

    The United States of America as represented by the Secretary of the Army · Granted Mar 22, 2005 · Expires Mar 17, 2025

    expired
  4. US 6869959

    Heterocyclic carboxylic acid derivatives

    Institute of Medicinal Molecular Design, Inc. · Granted Mar 22, 2005 · Expires Mar 17, 2025

    expired
  5. US 6867353

    Production method of recombinant rotavirus structural proteins and vaccine composition

    Exploregen Inc. · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  6. US 6867022

    Replication deficient adenovirus vectors and methods of making and using them

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  7. US 6867291

    Human hemicentin proteins and polynucleotides encoding the same

    Lexicon Genetics, Inc. · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  8. US 6867289

    Thio-modified aptamer synthetic methods and compositions

    The Board of Regents of the University of Texas System · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  9. US 6867190

    Methods of therapy with thrombin derived peptides

    The Board of Regents of the University of Texas System · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  10. US 6866845

    Compositions and methods for the treatment of sepsis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  11. US 6866844

    Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

    BIOMARIN PHARMACEUTICAL INC. · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  12. IS 7744

    Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi

    AMARIN NEUROSCIENCE LTD [GB] · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  13. US 2005054642

    Microbicidal composition based on formaldehyde donor compounds and antioxidants

    AIR LIQUIDE SANTE INT [FR] · Granted Mar 10, 2005 · Expires Mar 5, 2025

    expired
  14. US 6862890

    Process for production of nanoparticles and microparticles by spray freezing into liquid

    The Board of Regents of the University of Texas System · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  15. US 6864263

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  16. US 6863901

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Collegium Pharmaceutical, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  17. US 6864368

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  18. US 6864350

    Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics AL, Corporation · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  19. US 6864066

    Epithelial protein lost in neoplasm (EPLIN)

    The Regents of the University of California · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  20. US 6863887

    Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

    Northwest Biotherapeutics, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  21. US 6863885

    Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  22. US 6863693

    Phospholipid-coated implants

    University of Brighton · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  23. US 6863888

    Oncoprotein protein kinase

    The Regents of the University of California · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  24. US 6863895

    Mycobacterial sulfation pathway proteins and methods of use thereof

    The Regents of the University of California · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.